{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2878"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2878","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication?","abstract":"Title: Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication? Problem Statement: Midazolam remains the current choice within the practice for premedication in the prevention of emergence delirium, however as research continues there could possibly be a gap between the research and current practice. Throughout the practice of pediatric anesthesia most providers choose to premedicate with midazolam while there may be a more beneficial option of dexmedetomidine. Results: The study found a significant variance in the incidence of emergence delirium among pediatric patients, ranging from 18.1% to 89%, depending on the scoring system used. The PAED scoring system indicated an 89% incidence with a cutoff of 10 points, while a cutoff of 12 points showed 19.3%. Other scoring systems reported incidences of 18.1% and 18.9%. The findings highlight the variability in diagnosing emergence delirium based on different assessment tools. Overall, the research emphasizes the need for standardized criteria in evaluating the emergence of delirium in pediatric anesthesia.","abstract_html":"Title: Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication? Problem Statement: Midazolam remains the current choice within the practice for premedication in the prevention of emergence delirium, however as research continues there could possibly be a gap between the research and current practice. Throughout the practice of pediatric anesthesia most providers choose to premedicate with midazolam while there may be a more beneficial option of dexmedetomidine. Results: The study found a significant variance in the incidence of emergence delirium among pediatric patients, ranging from 18.1% to 89%, depending on the scoring system used. The PAED scoring system indicated an 89% incidence with a cutoff of 10 points, while a cutoff of 12 points showed 19.3%. Other scoring systems reported incidences of 18.1% and 18.9%. The findings highlight the variability in diagnosing emergence delirium based on different assessment tools. Overall, the research emphasizes the need for standardized criteria in evaluating the emergence of delirium in pediatric anesthesia.","abstract_has_math":false,"creators":["McCloud, Shelby"],"institution":null,"degree_name":"Management Practice in Nurse Anesthesia","degree_level":"Research Paper","degree_discipline":"College of Business","degree_department":null,"school":null,"contributors":["Megan E. Workman, DMP, APRN, CRNA","Alberto Coustasse, Dr.PH. MD, MBA, MPH"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:10Z","subjects":["Anesthesiology","Business Administration, Management, and Operations","Health and Medical Administration","Nursing","Pediatrics","midazolam","dexmedetomidine","premedication","pediatric patients","John Hopkins Evidence-Based practice model","Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1873","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1873","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2878","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Megan E. Workman, DMP, APRN, CRNA","Alberto Coustasse, Dr.PH. MD, MBA, MPH"]},{"key":"dc:creator","label":"Author","values":["McCloud, Shelby"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-09-04T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Business"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Research Paper"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Management Practice in Nurse Anesthesia"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Anesthesiology","Business Administration, Management, and Operations","Health and Medical Administration","Nursing","Pediatrics","midazolam","dexmedetomidine","premedication","pediatric patients","John Hopkins Evidence-Based practice model","Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1873"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Title: Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication? Problem Statement: Midazolam remains the current choice within the practice for premedication in the prevention of emergence delirium, however as research continues there could possibly be a gap between the research and current practice. Throughout the practice of pediatric anesthesia most providers choose to premedicate with midazolam while there may be a more beneficial option of dexmedetomidine. Results: The study found a significant variance in the incidence of emergence delirium among pediatric patients, ranging from 18.1% to 89%, depending on the scoring system used. The PAED scoring system indicated an 89% incidence with a cutoff of 10 points, while a cutoff of 12 points showed 19.3%. Other scoring systems reported incidences of 18.1% and 18.9%. The findings highlight the variability in diagnosing emergence delirium based on different assessment tools. Overall, the research emphasizes the need for standardized criteria in evaluating the emergence of delirium in pediatric anesthesia."]},{"key":"dc:title","label":"Title","values":["Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication?"]}]}],"canonical_facts":{"dc:contributor":["Megan E. Workman, DMP, APRN, CRNA","Alberto Coustasse, Dr.PH. MD, MBA, MPH"],"dc:creator":["McCloud, Shelby"],"dc:date.available":["2024-09-04T07:00:00Z"],"dc:date.created":["2024-01-01T08:00:00Z"],"dc:description.abstract":["Title: Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication? Problem Statement: Midazolam remains the current choice within the practice for premedication in the prevention of emergence delirium, however as research continues there could possibly be a gap between the research and current practice. Throughout the practice of pediatric anesthesia most providers choose to premedicate with midazolam while there may be a more beneficial option of dexmedetomidine. Results: The study found a significant variance in the incidence of emergence delirium among pediatric patients, ranging from 18.1% to 89%, depending on the scoring system used. The PAED scoring system indicated an 89% incidence with a cutoff of 10 points, while a cutoff of 12 points showed 19.3%. Other scoring systems reported incidences of 18.1% and 18.9%. The findings highlight the variability in diagnosing emergence delirium based on different assessment tools. Overall, the research emphasizes the need for standardized criteria in evaluating the emergence of delirium in pediatric anesthesia."],"dc:identifier":["https://mds.marshall.edu/etd/1873"],"dc:subject":["Anesthesiology","Business Administration, Management, and Operations","Health and Medical Administration","Nursing","Pediatrics","midazolam","dexmedetomidine","premedication","pediatric patients","John Hopkins Evidence-Based practice model","Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)"],"dc:title":["Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication?"],"thesis:degree_discipline":["College of Business"],"thesis:degree_level":["Research Paper"],"thesis:degree_name":["Management Practice in Nurse Anesthesia"]},"updated_at":"2026-11-21T19:58:10Z"}